omniture
BUCHAN CONSULTING PTY LTD

Latest News

Affinity discovers potent SARS-CoV-2 antibodies

MELBOURNE, Australia, July 2, 2020 /PRNewswire/ -- Melbourne-based Affinity Biosciences Pty Ltd (Af...

2020-07-02 12:25 4076

Alterity Therapeutics meeting with US FDA provides development pathway for ATH434

MELBOURNE, Australia and SAN FRANCISCO, June 29, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: A...

2020-06-30 11:14 5759

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology

MELBOURNE, Austrilia and SAN FRANCISCO, May 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: AT...

2020-05-21 08:58 5988

Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report

Highlights: * European Commission designated Orphan Drug status for ATH434's treatment of Multip...

2020-04-30 16:35 11094

Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement

MELBOURNE, Australia and SAN FRANCISCO, Feb. 7, 2020 /PRNewswire/ -- Alterity Therapeutics Limited ...

2020-02-07 21:00 11438

"Live bacteria" soil health and animal nutrition firm Terragen Holdings Ltd launches $20m IPO

* Australian agricultural microbial products company Terragen Holdings Ltd launches a$20 million ...

2019-11-05 06:10 2140

Admedus Inks $A36.2M Deal for CardioCel And VascuCel Patch Business

Transaction Highlights: * Admedus has sold the distribution rights to its CardioCel® and VascuCel...

2019-10-14 12:51 1352
1234